Hanmi Pharmaceutical Drives AI Transformation with Microsoft 365 Copilot and Surface Copilot+ PCs

Hanmi Pharmaceutical Advances AI Integration with Microsoft 365 Copilot and Surface Copilot+ PCs

Hanmi Pharmaceutical, a leader in Korean biopharmaceutical research and development, has taken a significant step in adopting AI technologies company-wide. The integration of Microsoft 365 Copilot and Surface Copilot+ PCs is part of their broader initiative to enhance productivity and security simultaneously.

AI-Driven Productivity and Security Enhancements

By deploying AI-enabled PC environments, Hanmi is streamlining workflows across departments. The use of Surface devices by sales teams allows real-time access to cloud-based data, enabling quick input and decision-making directly in the field. This approach reduces delays and improves the accuracy of information gathered during client interactions.

From Proof of Concept to Full Implementation

Hanmi’s AI transformation began with a proof of concept (PoC) in early 2024. Since then, integrating Microsoft 365 Copilot has led to noticeable improvements in workflow efficiency, helping employees save time on routine tasks and focus on higher-value activities.

Looking Ahead: Custom AI Agents and Advanced Solutions

The company plans to further develop AI capabilities by creating tailored AI agents using Copilot Studio and Azure AI Foundry. These efforts could lead to more personalized and intelligent tools that assist employees across various roles.

• Enhanced real-time data access for sales teams
• Improved workflow integration through Microsoft 365 Copilot
• Ongoing development of AI agents via Copilot Studio and Azure AI Foundry

For IT and development professionals interested in AI adoption strategies similar to Hanmi Pharmaceutical’s, exploring practical AI training can provide valuable skills. Resources like latest AI courses offer insights into deploying AI tools effectively within organizations.